Tevogen Bio Leverages Microsoft Partnership To Deliver Machine Learning Based Target Identification To Address HPV, Advancing TVGN 920

Benzinga11/05 22:29

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga11/05 00:40

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?

Benzinga11/05 00:05

Tevogen Bio Expands On Microsoft Partnership To Integrate Machine Learning And AI Into Preclinical Processes, Accelerating Drug Development And Reducing Costs; Says "Current Timeline For Drug Development Is 10-12 Years And Costs ~$1B-$3B. Approach Has...

Benzinga10/31 22:56

Tevogen Bio Reports That The Co Has Regained Nasdaq Listing Compliance

Benzinga10/30 03:37

Alpha Capital Appointed as Exclusive Financial Advisor to CD8 Technology to Secure Funding Up To $50 Million

GlobeNewswire10/30 02:38